THE PHARMAPORT™ ADVANTAGE FEATURING PRO-TECTIC™ TECHNOLOGY

  • Designed by experienced pharmaceutical refrigeration, preservation and controlled storage engineers.
  • Proprietary Pro-Tectic™ technology1 meets or exceeds World Health Organization "Cold Chain Storage and Distribution" guidelines and has been approved by the FAA.
  • Self-contained after charging, a non-invasive regenerative heat exchange thermal system1 eliminates HAZMAT costs associated with dry ice; uses no CO2 or LN2 and minimizes external impact on storage area, and reduces need for insulative packaging.
  • High-efficiency composite wall insulation is rated at >R70 to tolerate extreme ambient differentials while maintaining straight-line 5°C storage temperature.
  • Comprehensive data logging continues during charge and transport modes.
  • The 100% solid surface container base permits forklift access from all sides to simplify handling and warehousing, to optimize the center of gravity and to resist tipping.
  • Eliminates the need for a refrigerated truck and secondary insulated packaging.

1 US and International Patents Pending
 
pharma_advantage.png

Print Page Print Email us Email FaceBook  Linked In  Twitter Share